跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Eposis - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Eposis
Approved
STANDARD
Eposis
Daewoong Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70f1fcf710ac8e86
Company
Daewoong Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
70f1fcf710ac8e86
Drug Approval Philippines Name
Eposis
Product Name
Eposis
Registration Number
BR-859
Brand Name
Eposis
Generic Name
Recombinant Human Erythropoietin Alfa
Dosage Form
Solution For Injection (I.V./S.C.)
Dosage Strength
2000 I.U./0.5mL
Manufacturer
Daewoong Pharmaceutical Co., Ltd.
Importer
New Marketlink Pharmaceutical Corporation
Distributor
New Marketlink Pharmaceutical Corporation
Company Detail Path
/organization/daewoong-pharmaceutical-co-ltd
Issuance Date
21 April 2022
Expiry Date
16 April 2027
Pharmacologic Category
Hematopoietic Growth Factor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70f1fcf710ac8e86
Type
Standard
Back to Philippines FDA Approvals